Adaptimmune Therapeutics plc

NASDAQ: ADAP
Share price (8/12/25): $0.08
Market cap (8/12/25): $122 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Business combination disclosure

Ownership Filter

Two Seas Capital LP

EcoR1 Capital, LLC

Two Seas Capital LP

Bertrand William C JR

Brewer Joanna Elizabeth

News Filter

Reports Q2 Financial Results and Provides Business Update

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Unaudited Pro Forma Condensed Consolidated Financial Statements

Announces Entry Into Definitive Agreement for Sale of TECELRA, Lete-Cel, Afami-Cel and Uza-Cel Cell Therapies to US WorldMeds

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC